This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of tobramycin injection: A Synthesis of Findings from 1 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of tobramycin injection: A Synthesis of Findings from 1 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Two identically designed Phase 3, randomized, double-blind clinical trials have shown that once-daily oral sarecycline 1.5 mg/kg/day is effective for moderate to severe acne vulgaris. 1

Reasons for Side Effects

Side effects may limit the use of current tetracycline-class antibiotics for acne. 1

Common Side Effects

Gastrointestinal

Gastrointestinal issues are a common side effect of sarecycline. 1

Skin

Skin side effects are one of the common side effects of sarecycline. 1

Other

Other side effects of sarecycline reported include headache and dizziness. 1

Side Effects Management

Gastrointestinal

To minimize gastrointestinal side effects, sarecycline is recommended to be taken with food. 1

Skin

To reduce skin side effects, stop using sarecycline and consult your doctor. 1

Other

If you are concerned about side effects of sarecycline, talk to your doctor. 1

Comparison of Studies

Study Similarities

Both studies were identically designed Phase 3, randomized, double-blind clinical trials. Both demonstrated that once-daily oral sarecycline 1.5 mg/kg is effective for moderate to severe acne vulgaris. 1

Study Differences

The two studies differed in the age and gender composition of the participants. Additionally, the two studies had different durations of sarecycline administration. 1

Real-Life Application Notes

While sarecycline is an effective drug for treating acne vulgaris, there are risks of side effects. It is important to consult with your doctor and follow their instructions when using sarecycline. 1

Current Study Limitations

These studies did not evaluate the long-term safety and efficacy of sarecycline. Additionally, these studies did not compare sarecycline with other acne treatments. 1

Future Research Directions

Further research is needed to assess the long-term safety and efficacy of sarecycline. Comparative studies of sarecycline with other acne treatments are also needed. 1

Conclusion

Once-daily oral sarecycline 1.5 mg/kg is an effective drug for treating moderate to severe acne vulgaris. However, sarecycline carries the risk of side effects. It is important to consult with your doctor and follow their instructions when using sarecycline. 1


Keywords
Benefit Keywords
Risk Keywords
Literature analysis of 1 papers
Positive Content
1
Neutral Content
0
Negative Content
0
Article Type
1
0
0
0
1

Author: MooreAngela, GreenLawrence J, BruceSuzanne, SadickNeil, TschenEduardo, WerschlerPhilip, Cook-BoldenFran E, DhawanSunil S, ForshaDouglass, GoldMichael H, GuenthnerScott, KempersSteven E, KircikLeon H, ParishJennifer L, RendonMarta I, RichPhoebe, Stein-GoldLinda, TyringStephen K, WeissRobert A, NasirAdnan, SchmitzCarsten, BoodhooTerry I, KaoukhovAlexandre, BerkDavid R


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.